In a mouse model of T1DM, short-term treatment with D-Ala2-GIP prevented a decrease in bone formation parameters (collagen maturation index) and improved mechanical properties at the tissue level (Mansur et al., 2015). Here, GIP is linked to type 1 diabetes mellitus.